Red biotechnology is the biotechnological practice that aims at designing and manufacturing of biotechnological products and services in the medical and healthcare sector for diagnostic, therapeutic and preventive purposes. This segment contains something from the creation of an innovative medicine, vaccines, gene therapies and tissue engineering. Red biotechnology applies living organisms, cells and bio systems to develop drugs that can manage various diseases, and offer better patient care and optimum health solutions. With the development of the research field, the red biotechnology not only is continuously involved in the development of personalized medicine and regenerative medicine, but also has significant changes in the overall development of modern medical care.It is worth noting, that red biotechnology market is one of the most active and constantly changing segments of overall biotechnology industry, with stronger emphasis on healthcare and medical field. It covers virtually all types of goods and services and extends from biopharmaceuticals to gene therapy to regenerative medicine. The growth in this sector can further be attributed to factors like demographic change, especially aging population, emergent diseases, biotechnological research and development. Also, the increasing development of individualized medicine and targeted therapy will put pressure on the change of key driving forces such as the development of advanced biotechnological options in order to enhance the functioning of the entire system.

Regenerative medicine is the act of replacing or regenerating human cells, tissues, or organs in order to recover or restore normal function. This field has the potential to regenerate damaged tissues and organs in the body by either replacing damaged tissue or activating the body's healing processes to mend tissues or organs.